This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biomimetic Therapeutics, LLC. Active years: 2013-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2022
Title: The Innovations of Vivek Shah: Pioneering Treatments for Tendinopathies
Introduction
Vivek Shah, an accomplished inventor based in Franklin, TN, has made significant contributions to the field of medical innovations. With a total of four patents to his name, Shah has focused his research on the development of therapies aimed at treating various tendinopathies, benefiting countless individuals suffering from these conditions.
Latest Patents
One of Vivek Shah's noteworthy patents is centered on platelet-derived growth factor (PDGF) compositions. This innovative method provides compositions and strategies for treating tendinopathies such as tenosynovitis, tendinosis, and tendinitis. The applications extend to specific conditions like Achilles tendinopathy, patellar tendinopathy, lateral epicondylitis (tennis elbow), medial epicondylitis (golfer's elbow), plantar fasciitis, and rotator cuff tendinopathy. By utilizing platelet-derived growth factor, Shah's methods aim to enhance the healing processes and improve patient outcomes in these common ailments.
Career Highlights
Shah's professional journey is marked by his role at Biomimetic Therapeutics, LLC, a company specialized in developing innovative therapeutic solutions. His dedication to advancing medical science through creative inventions has positioned him as a valuable asset in the industry. The practical applications of his patents have the potential to transform treatment approaches within orthopedics and rehabilitation.
Collaborations
Throughout his career, Vivek Shah has collaborated with other esteemed professionals in his field, including coworkers Hans K Kestler and Dean James Rager-Aguiar. These partnerships reflect his commitment to interdisciplinary approaches, utilizing diverse expertise to enhance the efficacy and reach of his inventions.
Conclusion
Vivek Shah stands out as a forward-thinking inventor whose work has the potential to significantly improve the treatment of tendinopathies. His innovative use of platelet-derived growth factor underscores the important intersection of science and healthcare, showcasing how inventive solutions can lead to better patient care. As he continues to develop and refine his ideas, the medical community eagerly anticipates the impact of his future contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile